ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR
申请人:ABBOTT LABORATORIES
公开号:EP1534703A2
公开(公告)日:2005-06-01
[EN] ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR<br/>[FR] ANTAGONISTES DU RECEPTEUR DE L'HORMONE DE MELANO-CONCENTRATION
申请人:MILLENNIUM PHARM INC
公开号:WO2003106452A2
公开(公告)日:2003-12-24
This invention provides compounds that are antagonists of melanin concentrating hormone receptor-1 (MCH-R1). The compounds are represented by formula (I): where m is zero or one, n is zero to two, Y is oxygen or -N (R9)-, R1, R2, R3, R4, R5, R9, and Ring A are defined in the specification. Coumarin and quinolone compounds where R1 and R2 together form a fused benzo ring are preferred. The invention also provides compounds of formula (VI) where the coumarin moiety is replaced by a quinazolinone ring. The compounds are useful for treating MCH-R1-related disorders, particularly overweight conditions including obesity.
Piperidines and Azabicyclo Compounds. I. Via Michael Condensations